Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-003848-30Phase 2Completed
Phase 2 trial of diclofenac and heparin in hyperalgesia and None (4 arms), sponsored by IBSA Group. Primary endpoint: Primary efficacy endpoint. Started May 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-003848-30.